642 related articles for article (PubMed ID: 26170391)
1. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
[TBL] [Abstract][Full Text] [Related]
2. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
[TBL] [Abstract][Full Text] [Related]
3. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
[TBL] [Abstract][Full Text] [Related]
4. Human Langerhans cells capture measles virus through Langerin and present viral antigens to CD4⁺ T cells but are incapable of cross-presentation.
van der Vlist M; de Witte L; de Vries RD; Litjens M; de Jong MA; Fluitsma D; de Swart RL; Geijtenbeek TB
Eur J Immunol; 2011 Sep; 41(9):2619-31. PubMed ID: 21739428
[TBL] [Abstract][Full Text] [Related]
5. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells in distinct oral mucosal tissues engage different mechanisms to prime CD8+ T cells.
Nudel I; Elnekave M; Furmanov K; Arizon M; Clausen BE; Wilensky A; Hovav AH
J Immunol; 2011 Jan; 186(2):891-900. PubMed ID: 21160044
[TBL] [Abstract][Full Text] [Related]
7. Murine Langerin+ dermal dendritic cells prime CD8+ T cells while Langerhans cells induce cross-tolerance.
Flacher V; Tripp CH; Mairhofer DG; Steinman RM; Stoitzner P; Idoyaga J; Romani N
EMBO Mol Med; 2014 Sep; 6(9):1191-204. PubMed ID: 25085878
[TBL] [Abstract][Full Text] [Related]
8. Langerin+ CD8alpha+ dendritic cells are critical for cross-priming and IL-12 production in response to systemic antigens.
Farrand KJ; Dickgreber N; Stoitzner P; Ronchese F; Petersen TR; Hermans IF
J Immunol; 2009 Dec; 183(12):7732-42. PubMed ID: 19923446
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin.
Nasr N; Lai J; Botting RA; Mercier SK; Harman AN; Kim M; Turville S; Center RJ; Domagala T; Gorry PR; Olbourne N; Cunningham AL
J Immunol; 2014 Sep; 193(5):2554-64. PubMed ID: 25070850
[TBL] [Abstract][Full Text] [Related]
10. Glyco-Dendrimers as Intradermal Anti-Tumor Vaccine Targeting Multiple Skin DC Subsets.
Duinkerken S; Horrevorts SK; Kalay H; Ambrosini M; Rutte L; de Gruijl TD; Garcia-Vallejo JJ; van Kooyk Y
Theranostics; 2019; 9(20):5797-5809. PubMed ID: 31534520
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
Holla A; Skerra A
Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
[TBL] [Abstract][Full Text] [Related]
12. Langerin, the "Catcher in the Rye": an important receptor for pathogens on Langerhans cells.
Stoitzner P; Romani N
Eur J Immunol; 2011 Sep; 41(9):2526-9. PubMed ID: 21952811
[TBL] [Abstract][Full Text] [Related]
13. Despite differences between dendritic cells and Langerhans cells in the mechanism of papillomavirus-like particle antigen uptake, both cells cross-prime T cells.
Yan M; Peng J; Jabbar IA; Liu X; Filgueira L; Frazer IH; Thomas R
Virology; 2004 Jul; 324(2):297-310. PubMed ID: 15207617
[TBL] [Abstract][Full Text] [Related]
14. Skin langerin+ dendritic cells transport intradermally injected anti-DEC-205 antibodies but are not essential for subsequent cytotoxic CD8+ T cell responses.
Flacher V; Tripp CH; Haid B; Kissenpfennig A; Malissen B; Stoitzner P; Idoyaga J; Romani N
J Immunol; 2012 Mar; 188(5):2146-55. PubMed ID: 22291181
[TBL] [Abstract][Full Text] [Related]
15. Langerin functions as an antiviral receptor on Langerhans cells.
van der Vlist M; Geijtenbeek TB
Immunol Cell Biol; 2010; 88(4):410-5. PubMed ID: 20309013
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 mediated uptake via langerin restricts HIV-1 infection in human Langerhans cells.
van den Berg LM; Ribeiro CM; Zijlstra-Willems EM; de Witte L; Fluitsma D; Tigchelaar W; Everts V; Geijtenbeek TB
Retrovirology; 2014 Dec; 11():123. PubMed ID: 25551286
[TBL] [Abstract][Full Text] [Related]
17. Langerin+ dermal dendritic cells are critical for CD8+ T cell activation and IgH γ-1 class switching in response to gene gun vaccines.
Stoecklinger A; Eticha TD; Mesdaghi M; Kissenpfennig A; Malissen B; Thalhamer J; Hammerl P
J Immunol; 2011 Feb; 186(3):1377-83. PubMed ID: 21187444
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
[TBL] [Abstract][Full Text] [Related]
19. Langerin-mediated internalization of a modified peptide routes antigens to early endosomes and enhances cross-presentation by human Langerhans cells.
Fehres CM; Duinkerken S; Bruijns SC; Kalay H; van Vliet SJ; Ambrosini M; de Gruijl TD; Unger WW; Garcia-Vallejo JJ; van Kooyk Y
Cell Mol Immunol; 2017 Apr; 14(4):360-370. PubMed ID: 26456691
[TBL] [Abstract][Full Text] [Related]
20. CD8 alpha- and Langerin-negative dendritic cells, but not Langerhans cells, act as principal antigen-presenting cells in leishmaniasis.
Ritter U; Meissner A; Scheidig C; Körner H
Eur J Immunol; 2004 Jun; 34(6):1542-50. PubMed ID: 15162423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
